E. David Crawford is joined by Badrinath Konety, MD for a video lecture on novel bladder cancer markers and currently available bladder cancer markers and how they can possibly be applied to the practice of urology and potential bladder cancer markers that are in the pipeline.

Biography:
Badrinath R. Konety, M.D., M.B.A., is Professor and Chair of the Department of Urology and holds the Dougherty Family Chair in Uro-Oncology as well as being the Director of the Institute for Prostate and Urologic Cancers and Associate Director for Clinical Affairs of the Masonic Cancer Center at the University of Minnesota.

Badrinath Konety, M.D., completed his residency and American Foundation for Urologic Disease Research Scholar fellowship at the University of Pittsburgh. He also received an MBA from the University of Pittsburgh Katz School of Business. Dr. Konety also completed his urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. 

Additional reading on bladder cancer biomarkers:

• Bladder Cancer BioMarkers: Optimal Utilization for Diagnosis and Recurrence
• Point- CounterPoint: Are Novel Biomarkers Ready For Primetime in Routine Detection of Prostate Cancer?: Badrinath Konety
• Point - CounterPoint: Are Novel Biomarkers Ready For Primetime in Routine Detection of Prostate Cancer?: Scott Eggener